Business · 12/09/2014Updated: 10/17/2026 · 1 min read
FDA Amends Notice of Joint Meeting of Psychopharmacologic Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee
Summary
The FDA is updating the notice for a joint meeting of two advisory committees, originally announced on April 25, 2014, with no other changes to the agenda.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →